Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease | Zendy

Davide Bolignano | Zendy; Antonio Lacquaniti | Zendy; Giuseppe Coppolino | Zendy; Valentina Donato | Zendy; Susanna Campo | Zendy; Maria Rosaria Fazio | Zendy; Giacomo Nicocia | Zendy; Michele Buemi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease

Author(s) -

Davide Bolignano,

Antonio Lacquaniti,

Giuseppe Coppolino,

Valentina Donato,

Susanna Campo,

Maria Rosaria Fazio,

Giacomo Nicocia,

Michele Buemi

Publication year - 2009

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.03530708

Subject(s) - medicine , kidney disease , renal function , creatinine , biomarker , lipocalin , proteinuria , hazard ratio , proportional hazards model , urinary system , gastroenterology , urology , kidney , confidence interval , biochemistry , chemistry

Chronic kidney disease (CKD) has recently assumed epidemic proportion, becoming a troubling emerging cause of morbidity, especially if it progresses to terminal stage (ESRD). The authors aimed to evaluate whether neutrophil gelatinase-associated lipocalin (NGAL), a novel specific biomarker of acute kidney injury, could predict the progression of CKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research